IGFBP3 and esophageal squamous cell carcinoma: There is evidence that levels of IGFBP-3 in EGFR-overexpressing ESCC cells are responsible, for the increased radiosensitivity conferred by nimotuzumab, which improved the radiosensitivity of ESCC cells with high EGFR expression17.